BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 30756440)

  • 41. Survival benefit of nephroureterectomy in systemic therapy exposed metastatic upper tract urinary urothelial carcinoma patients.
    Morra S; Incesu RB; Scheipner L; Baudo A; Jannello LMI; Siech C; de Angelis M; Tian Z; Creta M; Califano G; Collà Ruvolo C; Saad F; Shariat SF; Chun FKH; de Cobelli O; Musi G; Briganti A; Tilki D; Ahyai S; Carmignani L; Longo N; Karakiewicz PI
    World J Urol; 2024 May; 42(1):343. PubMed ID: 38775841
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Impact of lymph node dissection on cancer specific survival in patients with upper tract urothelial carcinoma treated with radical nephroureterectomy.
    Roscigno M; Shariat SF; Margulis V; Karakiewicz P; Remzi M; Kikuchi E; Langner C; Lotan Y; Weizer A; Bensalah K; Raman JD; Bolenz C; Guo CC; Wood CG; Zigeuner R; Wheat J; Kabbani W; Koppie TM; Ng CK; Suardi N; Bertini R; Fernández MI; Mikami S; Isida M; Michel MS; Montorsi F
    J Urol; 2009 Jun; 181(6):2482-9. PubMed ID: 19371878
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Trends in utilisation, perioperative outcomes, and costs of nephroureterectomies in the management of upper tract urothelial carcinoma: a 10-year population-based analysis.
    Tinay I; Gelpi-Hammerschmidt F; Leow JJ; Allard CB; Rodriguez D; Wang Y; Chung BI; Chang SL
    BJU Int; 2016 Jun; 117(6):954-60. PubMed ID: 26573216
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Laparoscopy versus Open Nephroureterectomy in Prognostic Outcome of Patients with Advanced Upper Tract Urothelial Cancer: A Retrospective, Multicenter, Propensity-Score Matching Analysis.
    Kim SH; Song MK; Kim JK; Hong B; Kang SH; Ku JH; Jeong BC; Seo HK
    Cancer Res Treat; 2019 Jul; 51(3):963-972. PubMed ID: 30322230
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Robot-assisted versus open radical nephroureterectomy for urothelial carcinoma of the upper urinary tract: A retrospective cohort study across ten years.
    Zeuschner P; Vollmer SG; Linxweiler J; Wagenpfeil G; Wagenpfeil S; Saar M; Siemer S; Stöckle M; Heinzelbecker J
    Surg Oncol; 2021 Sep; 38():101607. PubMed ID: 34022505
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Segmental Ureterectomy is Acceptable for High-risk Ureteral Carcinoma Comparing to Radical Nephroureterectomy.
    Huang Z; Zhang X; Zhang X; Li Q; Liu S; Yu L; Xu T
    J Invest Surg; 2019 Dec; 32(8):746-753. PubMed ID: 29693458
    [No Abstract]   [Full Text] [Related]  

  • 47. Association between lymph node yield and survival among patients undergoing radical nephroureterectomy for urothelial carcinoma of the upper tract.
    Zareba P; Rosenzweig B; Winer AG; Coleman JA
    Cancer; 2017 May; 123(10):1741-1750. PubMed ID: 28152158
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Comparison of oncological outcomes for open and laparoscopic radical nephroureterectomy: results from the Canadian Upper Tract Collaboration.
    Fairey AS; Kassouf W; Estey E; Tanguay S; Rendon R; Bell D; Izawa J; Chin J; Kapoor A; Matsumoto E; Black P; So A; Lattouf JB; Saad F; Drachenberg D; Cagiannos I; Lacombe L; Fradet Y; Jacobsen NE
    BJU Int; 2013 Oct; 112(6):791-7. PubMed ID: 23148712
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Location of the primary tumor is not an independent predictor of cancer specific mortality in patients with upper urinary tract urothelial carcinoma.
    Isbarn H; Jeldres C; Shariat SF; Liberman D; Sun M; Lughezzani G; Widmer H; Arjane P; Pharand D; Fisch M; Graefen M; Montorsi F; Perrotte P; Karakiewicz PI
    J Urol; 2009 Nov; 182(5):2177-81. PubMed ID: 19758662
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Treatment utilization and overall survival in patients receiving radical nephroureterectomy versus endoscopic management for upper tract urothelial carcinoma: evaluation of updated treatment guidelines.
    Upfill-Brown A; Lenis AT; Faiena I; Salmasi AH; Johnson DC; Pooli A; Drakaki A; Gollapudi K; Blumberg J; Pantuck AJ; Chamie K
    World J Urol; 2019 Jun; 37(6):1157-1164. PubMed ID: 30267197
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Tumor necrosis predicts poor clinical outcomes in patients with node-negative upper urinary tract urothelial carcinoma.
    Zhang XK; Zhang ZL; Yang P; Cai MY; Hu WM; Yun JP; Zhou FJ; Qian CN; Cao Y
    Jpn J Clin Oncol; 2015 Nov; 45(11):1069-75. PubMed ID: 26355163
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Laparoscopic radical nephroureterectomy: a multicenter analysis in Japan.
    Kamihira O; Hattori R; Yamaguchi A; Kawa G; Ogawa O; Habuchi T; Kawauchi A; Uozumi J; Yokoi S; Tsujihata M; Hasui Y; Miyakoda K; Tada H; Ono Y; Naito S
    Eur Urol; 2009 Jun; 55(6):1397-407. PubMed ID: 19299072
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Editorial comment on: Laparoscopic radical nephroureterectomy: a multicenter analysis in Japan.
    Touijer K
    Eur Urol; 2009 Jun; 55(6):1409. PubMed ID: 19299068
    [No Abstract]   [Full Text] [Related]  

  • 54. Editorial comment on: Laparoscopic radical nephroureterectomy: a multicenter analysis in Japan.
    Autorino R; Falsaperla M
    Eur Urol; 2009 Jun; 55(6):1408. PubMed ID: 19299070
    [No Abstract]   [Full Text] [Related]  

  • 55. Laparoscopic nephroureterectomy for upper urinary tract transitional cell carcinoma: is it better than open surgery?
    Rassweiler JJ; Schulze M; Marrero R; Frede T; Palou Redorta J; Bassi P
    Eur Urol; 2004 Dec; 46(6):690-7. PubMed ID: 15548434
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Significant clinicopathologic prognostic factors for bladder recurrence, progression, and cancer-specific survival after surgery among patients with upper urinary tract urothelial carcinoma.
    Kim SH; Song MK; Joung JY; Chung J; Lee KH; Seo HK
    Investig Clin Urol; 2019 Nov; 60(6):432-442. PubMed ID: 31692890
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Impact of post-void residual urine volume on intravesical recurrence after nephroureterectomy for upper urinary tract urothelial carcinoma.
    Sazuka T; Sakamoto S; Nakamura K; Imamura Y; Yamamoto S; Komiya A; Ichikawa T
    Int J Urol; 2019 Dec; 26(12):1106-1112. PubMed ID: 31522458
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Oncologic Outcomes of Kidney-sparing Surgery Versus Radical Nephroureterectomy for Upper Tract Urothelial Carcinoma: A Systematic Review by the EAU Non-muscle Invasive Bladder Cancer Guidelines Panel.
    Seisen T; Peyronnet B; Dominguez-Escrig JL; Bruins HM; Yuan CY; Babjuk M; Böhle A; Burger M; Compérat EM; Cowan NC; Kaasinen E; Palou J; van Rhijn BW; Sylvester RJ; Zigeuner R; Shariat SF; Rouprêt M
    Eur Urol; 2016 Dec; 70(6):1052-1068. PubMed ID: 27477528
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Role of lymph node dissection during radical nephroureterectomy for upper urinary tract urothelial cancer: multi-institutional large retrospective study JCOG1110A.
    Inokuchi J; Kuroiwa K; Kakehi Y; Sugimoto M; Tanigawa T; Fujimoto H; Gotoh M; Masumori N; Ogawa O; Eto M; Ohyama C; Yamaguchi A; Matsuyama H; Ichikawa T; Asano T; Mizusawa J; Eba J; Naito S
    World J Urol; 2017 Nov; 35(11):1737-1744. PubMed ID: 28508102
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Impact of tumour location versus multifocality in patients with upper tract urothelial carcinoma treated with nephroureterectomy and bladder cuff excision: a homogeneous series without perioperative chemotherapy.
    Yafi FA; Novara G; Shariat SF; Gupta A; Matsumoto K; Walton TJ; Fritsche HM; El-Hakim A; Trischler S; Martínez-Salamanca JI; Seitz C; Ficarra V; Zattoni F; Karakiewicz PI; Kassouf W
    BJU Int; 2012 Jul; 110(2 Pt 2):E7-13. PubMed ID: 22177329
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.